Stock Quote

Sanofi-Aventis S.A. (SASY.PA) (Paris Stock Exchange)
As of  20 Nov 2009
50.37EUR
Price Change
+0.07
Percent Change
+0.14%
 
€50.37
20 Nov 2009
+0.14%
€50.30
€50.24
3,977,953
€50.71
€49.73
€53.90
€38.43
0.58
2,613,866

Research Another Stock: Symbol Look-up
Swine flu may have hit one peak; more to come
Friday, 20 Nov 2009 05:45pm EST 
Swine flu may have hit one peak; more to come
Friday, 20 Nov 2009 04:58pm EST 
Swine flu may be peaking in U.S.   |  Video
Friday, 20 Nov 2009 04:27pm EST 
Complete List of Chilean ADR Stocks
Monday, 26 Oct 2009 09:17am EDT(Seeking Alpha) 
Merck Tops Street Ahead of Schering Merger
Thursday, 22 Oct 2009 10:27am EDT(The Street) 
North American and European Bank Rankings - September 2009
Tuesday, 6 Oct 2009 05:52am EDT(Seeking Alpha) 
Get Ready for the Fall?
Monday, 28 Sep 2009 09:47am EDT(The Motley Fool) 
 
Name Current Position Compensation
Dehecq, Jean-Francois Chairman of the Board 2,214,850
Viehbacher, Christopher Managing Director (CEO), Member of the Executive Committee, Director 106,016
Contamine, Jerome Chief Financial Officer --

Profile

Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. The Company's business includes two main activities: pharmaceuticals and human vaccines through sanofi pasteur. In its pharmaceutical activity, Sanofi-Aventis specializes... Full Description

Company Address

Sanofi-Aventis S.A.
174 avenue de France
cedex 13
Paris     75635
P: +331.53774000
F: +331.53774296

Analyst Research

  SASY.PA Industry
P/E(TTM) 15.51 6.90
P/S(TTM) 2.16 1.54
ROI(TTM) -- 6.18
ROE(TTM) -- 9.32
Consensus Recommendation Outperform
EPS Est. (Current Period) --
EPS Est. (Current Year) --
Total Revenue $7,772.00M
Net Income $1,254.00M
EPS $1.09